TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
NERV

Minerva Neurosciences Inc

Healthcare · Biotechnology

3.40$ -1.5% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement NERV
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – 100.0% 100.0% – – – – –
– – – – – 0.4% 0.4% – – – – –
– – – – – -0.4% 100.0% – – – – –
– – – – – 141.2% 53.5% – – – – –
– – – – – 43.1% 42.0% – – – – –
– – – – – 184.2% 95.5% – – – – –
– – – – – -184.2% 4.5% – – – – –
– – – – – 3.9% 0.0% – – – – –
– – – – – -180.8% 4.7% – – – – –
– – – – – -5.5% -0.2% – – – – –
– – – – – -175.3% 4.7% – – – – –
– – – – – -180.4% 5.1% – – – – –

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?